Annotation Detail
Information
- Associated Genes
- PTEN
- Associated Variants
-
PTEN DELETION
(
ENST00000371953.8 )
PTEN DELETION ( ENST00000371953.8 ) - Associated Disease
- cancer
- Source Database
- CIViC Evidence
- Description
- All three patients with PTEN loss had benefit from adding Buparlisib to carboplatin+paclitaxel therapy in a phase I study in advanced solid cancers.
- Variant Origin
- somatic
- Variant Origin
- Somatic
- Evidence URL
- https://civic.genome.wustl.edu/links/evidence_items/714
- Gene URL
- https://civic.genome.wustl.edu/links/genes/41
- Variant URL
- https://civic.genome.wustl.edu/links/variants/214
- Rating
- 3
- Evidence Type
- Predictive
- Disease
- Cancer
- Evidence Direction
- Supports
- Drug
- Paclitaxel,Carboplatin,Buparlisib
- Evidence Level
- B
- Clinical Significance
- Sensitivity/Response
- Pubmed
- 25672916
Drugs
Drug Name | Sensitivity | Supported |
---|---|---|
Buparlisib | Sensitivity | true |
Carboplatin | Sensitivity | true |
Paclitaxel | Sensitivity | true |